ATE365740T1 - Substituierte pyrazolopyrimidine - Google Patents
Substituierte pyrazolopyrimidineInfo
- Publication number
- ATE365740T1 ATE365740T1 AT03726540T AT03726540T ATE365740T1 AT E365740 T1 ATE365740 T1 AT E365740T1 AT 03726540 T AT03726540 T AT 03726540T AT 03726540 T AT03726540 T AT 03726540T AT E365740 T1 ATE365740 T1 AT E365740T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted pyrazolopyrimidines
- same
- pyrazolopyrimidines
- substituted
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37942102P | 2002-05-10 | 2002-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365740T1 true ATE365740T1 (de) | 2007-07-15 |
Family
ID=29420528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03726540T ATE365740T1 (de) | 2002-05-10 | 2003-04-30 | Substituierte pyrazolopyrimidine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7304068B2 (de) |
| EP (1) | EP1504004B1 (de) |
| JP (1) | JP2005529919A (de) |
| AT (1) | ATE365740T1 (de) |
| AU (1) | AU2003228770A1 (de) |
| DE (1) | DE60314623T2 (de) |
| ES (1) | ES2287476T3 (de) |
| WO (1) | WO2003095455A2 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60301339T2 (de) | 2002-03-07 | 2006-03-09 | Smithkline Beecham Corp. | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen |
| US7196078B2 (en) | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| FR2859729B1 (fr) * | 2003-09-12 | 2006-02-24 | Roquette Freres | Dispersions aqueuses d'au moins un polymere biodegradable |
| TW200639163A (en) | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| EP2308866A1 (de) | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide |
| CN102762551A (zh) | 2009-12-21 | 2012-10-31 | 拜尔农作物科学股份公司 | 噻吩基吡(嘧)啶基吡唑及其用于防治植物致病菌的用途 |
| AR081810A1 (es) | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | Piridinilpirazoles biciclicos |
| PT3012258T (pt) | 2010-06-24 | 2018-12-14 | Gilead Sciences Inc | Composição farmacêutica compreendendo um derivado de pirazolo[1,5-a]pirimidina como agente antiviral |
| AU2015200638B2 (en) * | 2010-06-24 | 2016-11-10 | Gilead Sciences, Inc. | Pyrazolo [1, 5 -a] pyrimidines as antiviral agents |
| EP2402344A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolkondensierte bicyclische Verbindungen |
| EP2402343A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole kondensierte bizyclische Verbindungen |
| EP2402337A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridin-Verbindungen |
| EP2402345A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole kondensierte bizyclische Verbindungen |
| AR086992A1 (es) | 2011-06-20 | 2014-02-05 | Bayer Ip Gmbh | Tienilpiri(mi)dinilpirazoles |
| US8633198B1 (en) | 2011-09-20 | 2014-01-21 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
| MX355016B (es) | 2011-10-06 | 2018-04-02 | Bayer Ip Gmbh | Heterociclilpiri(mi)dinilpirazoles como fungicidas. |
| JP6211522B2 (ja) | 2011-10-06 | 2017-10-11 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | ヘテロシクリルピリ（ミ）ジニルピラゾール |
| JP6122868B2 (ja) * | 2011-12-22 | 2017-04-26 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン |
| AU2013249280B2 (en) | 2012-04-17 | 2017-10-12 | Gilead Sciences, Inc. | Compounds and methods for antiviral treatment |
| KR101868128B1 (ko) * | 2013-12-11 | 2018-06-18 | 난트 홀딩스 아이피, 엘엘씨 | 인플루엔자 a rna-의존성 rna 폴리머라제의 저분자 저해제 |
| WO2015097121A1 (en) | 2013-12-23 | 2015-07-02 | Norgine B.V. | Compounds useful as ccr9 modulators |
| JP6509238B2 (ja) * | 2014-01-22 | 2019-05-08 | キュロヴィル・アクチボラグ | 治療に有用なピラゾロ［１，５−ａ］ピリミジン−７−アミン誘導体 |
| WO2016091774A1 (en) * | 2014-12-08 | 2016-06-16 | Janssen Sciences Ireland Uc | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
| US11155560B2 (en) | 2018-10-30 | 2021-10-26 | Kronos Bio, Inc. | Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity |
| JP2024508761A (ja) * | 2020-12-18 | 2024-02-28 | ザ スクリプス リサーチ インスティテュート | 神経変性、変性及び代謝性障害の処置のための化合物並びにその使用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356897A (en) | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
| JPH11505524A (ja) | 1995-05-01 | 1999-05-21 | 藤沢薬品工業株式会社 | イミダゾ１，２−ａピリジンおよびイミダゾ１，２−ａピリデジン誘導体、および骨吸収阻害剤としてのその用途 |
| US6313124B1 (en) * | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
| US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
| US6191131B1 (en) * | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| IL132736A0 (en) | 1997-05-22 | 2001-03-19 | Searle & Co | 3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| JP2002501532A (ja) | 1997-05-30 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 新規血管形成阻害薬 |
| JP2000038350A (ja) | 1998-05-18 | 2000-02-08 | Yoshitomi Pharmaceut Ind Ltd | 糖尿病治療薬 |
| US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
-
2003
- 2003-04-30 JP JP2004503469A patent/JP2005529919A/ja active Pending
- 2003-04-30 WO PCT/US2003/013395 patent/WO2003095455A2/en not_active Ceased
- 2003-04-30 US US10/512,916 patent/US7304068B2/en not_active Expired - Fee Related
- 2003-04-30 AT AT03726540T patent/ATE365740T1/de not_active IP Right Cessation
- 2003-04-30 DE DE60314623T patent/DE60314623T2/de not_active Expired - Fee Related
- 2003-04-30 AU AU2003228770A patent/AU2003228770A1/en not_active Abandoned
- 2003-04-30 ES ES03726540T patent/ES2287476T3/es not_active Expired - Lifetime
- 2003-04-30 EP EP03726540A patent/EP1504004B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2287476T3 (es) | 2007-12-16 |
| AU2003228770A1 (en) | 2003-11-11 |
| EP1504004A2 (de) | 2005-02-09 |
| DE60314623T2 (de) | 2008-02-28 |
| EP1504004B1 (de) | 2007-06-27 |
| US7304068B2 (en) | 2007-12-04 |
| AU2003228770A8 (en) | 2003-11-11 |
| WO2003095455A3 (en) | 2003-12-24 |
| JP2005529919A (ja) | 2005-10-06 |
| DE60314623D1 (de) | 2007-08-09 |
| US20050203106A1 (en) | 2005-09-15 |
| WO2003095455A2 (en) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60314623D1 (de) | Substituierte pyrazolopyrimidine | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
| ATE301653T1 (de) | Pyrazolopyridine | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| SE0301700D0 (sv) | Novel compounds | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
| SE0302811D0 (sv) | Novel compounds | |
| SE0200920D0 (sv) | Novel compounds | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| SE0202539D0 (sv) | Compounds | |
| CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
| SE0202133D0 (sv) | Novel compounds | |
| SE0302139D0 (sv) | Novel compounds | |
| ATE302203T1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
| DE60220525D1 (de) | Pyrazolo-pyridine für die behandlung von herpes-ansteckungen | |
| MXPA05012247A (es) | Derivados de bencimidazol nuevos. | |
| SE0303541D0 (sv) | New compounds | |
| SE0102716D0 (sv) | Novel compounds | |
| SE0303280D0 (sv) | Novel compounds | |
| ATE373000T1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| ATE251162T1 (de) | Triazolo(4,5-d)pyrimidin-verbindungen | |
| SE0302755D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |